Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Sep 6;52(3):1801485.
doi: 10.1183/13993003.01485-2018. Print 2018 Sep.

Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies

Luca Richeldi  1 , Kevin C Wilson  2 , Ganesh Raghu  3
Affiliations
Free article
Editorial

Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies

Luca Richeldi et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: L. Richeldi reports personal fees from Sanofi-Aventis (consultancy), Roche (member of advisory board), Celgene (consultancy), Nitto (consultancy), Fibrogen (member of advisory board), Promedior (member of advisory board), Bristol Myers Squibb (consultancy), DynaMed (editorial activity), Pliant Therapeutics (consultancy), Prometic (consultancy), Asahi Kasei (consultancy) and Biogen (consultancy), and grants and personal fees from Boehringer Ingelheim (member of Steering Committee), all outside the submitted work. Conflict of interest: K.C. Wilson reports being the American Thoracic Society Chief of Documents and Patient Education; therefore, he may have an intellectual bias in favour of ATS-sponsored documents. Conflict of interest: G. Raghu reports other (consultant for IPF studies) from BI, BMS, Biogen, Bellerophan, Fibrogen, Gilead, Nitto, Promedior, Sanofi and Veracyte, and grants from NIH (for IPF studies), all outside the submitted work.

Comment on

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
    Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU. Lynch DA, et al. Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15. Lancet Respir Med. 2018. PMID: 29154106 Review.
  • Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
    Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Raghu G, et al. Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST. Am J Respir Crit Care Med. 2018. PMID: 30168753

LinkOut - more resources